Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 2
1998 2
1999 3
2000 3
2001 3
2002 7
2003 2
2004 2
2005 6
2006 5
2007 4
2008 4
2009 5
2010 6
2011 6
2012 5
2013 4
2014 6
2015 3
2016 4
2017 3
2018 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

78 results
Results by year
Filters applied: . Clear all
Page 1
[Transglutaminase and neurodegenerative diseases].
Liu Z, Zeng J, Zeng S, Tang B, Wang J. Liu Z, et al. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2015 Aug;32(4):562-6. doi: 10.3760/cma.j.issn.1003-9406.2015.04.025. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2015. PMID: 26252108 Review. Chinese.
TGase has been found to contribute to a variety of important physiological and pathological processes and play a role in the pathogenesis of multiple diseases. Notably, neurodegenerative diseases such as Huntington's disease, spinocerebellar ataxia, Alzheimer's
TGase has been found to contribute to a variety of important physiological and pathological processes and play a role in the pathogenesis of …
Transglutaminase inhibitors: a patent review.
Keillor JW, Apperley KY. Keillor JW, et al. Expert Opin Ther Pat. 2016;26(1):49-63. doi: 10.1517/13543776.2016.1115836. Epub 2015 Nov 24. Expert Opin Ther Pat. 2016. PMID: 26560530 Review.
Their protein-crosslinking activity has been linked to fibrosis and Huntington's disease, their glutamine deamidation activity has been related to celiac disease and their GTP-binding activity has been implicated in cancer. ...AREAS COVERED: This review presents an …
Their protein-crosslinking activity has been linked to fibrosis and Huntington's disease, their glutamine deamidation activity …
Tissue transglutaminase (TG2) and mitochondrial function and dysfunction.
Lai TS, Lin CJ, Wu YT, Wu CJ. Lai TS, et al. Front Biosci (Landmark Ed). 2017 Mar 1;22(7):1114-1137. doi: 10.2741/4536. Front Biosci (Landmark Ed). 2017. PMID: 28199195 Free article. Review.
Mitochondria are the cell's power plant to satisfy the energy demands. However, dysfunctional mitochondria can cause overproduction of reactive oxygen species (ROS), oxidative stress, and alteration of calcium homeostasis, which are the hallmarks of mitochondrial diseases. …
Mitochondria are the cell's power plant to satisfy the energy demands. However, dysfunctional mitochondria can cause overproduction o …
Type 2 Transglutaminase, mitochondria and Huntington's disease: menage a trois.
Altuntas S, D'Eletto M, Rossin F, Hidalgo LD, Farrace MG, Falasca L, Piredda L, Cocco S, Mastroberardino PG, Piacentini M, Campanella M. Altuntas S, et al. Mitochondrion. 2014 Nov;19 Pt A:97-104. doi: 10.1016/j.mito.2014.09.008. Epub 2014 Sep 28. Mitochondrion. 2014. PMID: 25262960 Review.
New insight into transglutaminase 2 and link to neurodegenerative diseases.
Min B, Chung KC. Min B, et al. BMB Rep. 2018 Jan;51(1):5-13. doi: 10.5483/bmbrep.2018.51.1.227. BMB Rep. 2018. PMID: 29187283 Free PMC article. Review.
Formation of toxic protein aggregates is a common feature and mainly contributes to the pathogenesis of neurodegenerative diseases (NDDs), which include amyotrophic lateral sclerosis (ALS), Alzheimer's, Parkinson's, Huntington's, and prion diseases. Th …
Formation of toxic protein aggregates is a common feature and mainly contributes to the pathogenesis of neurodegenerative diseases (NDDs), w …
Transglutaminase is linked to neurodegenerative diseases.
Muma NA. Muma NA. J Neuropathol Exp Neurol. 2007 Apr;66(4):258-63. doi: 10.1097/nen.0b013e31803d3b02. J Neuropathol Exp Neurol. 2007. PMID: 17413316 Review.
Similar changes in transglutaminase and transglutaminase-modified proteins are replicated in transgenic mouse models of the neurodegenerative diseases, including Huntington disease and progressive supranuclear palsy. Lastly, inhibition of transglutaminase either via drug t …
Similar changes in transglutaminase and transglutaminase-modified proteins are replicated in transgenic mouse models of the neurodegenerativ …
Transglutaminase and diseases of the central nervous system.
Hoffner G, Djian P. Hoffner G, et al. Front Biosci. 2005 Sep 1;10:3078-92. doi: 10.2741/1764. Front Biosci. 2005. PMID: 15970562 Review.
Alzheimer's disease, Parkinson's disease and diseases of expanded polyglutamine are associated with insoluble protein aggregates and neuronal death. ...
Alzheimer's disease, Parkinson's disease and diseases of expanded polyglutamine are associated with insoluble protein aggregat …
Possible involvement of transglutaminase-catalyzed reactions in the physiopathology of neurodegenerative diseases.
Martin A, Giuliano A, Collaro D, De Vivo G, Sedia C, Serretiello E, Gentile V. Martin A, et al. Amino Acids. 2013 Jan;44(1):111-8. doi: 10.1007/s00726-011-1081-1. Epub 2011 Sep 22. Amino Acids. 2013. PMID: 21938398 Review.
Transglutaminase activity has been hypothesized to be involved also in the pathogenetic mechanisms responsible for human neurodegenerative diseases. Neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, supranuclear palsy, Huntington' …
Transglutaminase activity has been hypothesized to be involved also in the pathogenetic mechanisms responsible for human neurodegenerative d …
Tissue transglutaminase: a possible role in neurodegenerative diseases.
Lesort M, Tucholski J, Miller ML, Johnson GV. Lesort M, et al. Prog Neurobiol. 2000 Aug;61(5):439-63. doi: 10.1016/s0301-0082(99)00052-0. Prog Neurobiol. 2000. PMID: 10748319 Review.
Recent findings have provided evidence that dysregulation of tissue transglutaminase may contribute to the pathology of several neurodegenerative conditions including Alzheimer's disease and Huntington's disease. In both of these diseases tissue transglutamin …
Recent findings have provided evidence that dysregulation of tissue transglutaminase may contribute to the pathology of several neurodegener …
Transglutaminase activity as a possible therapeutical target in neurodegenerative diseases.
Iannaccone M, Titta F, Serretiello E, De Vivo G, Martin A, Gentile V. Iannaccone M, et al. Recent Pat CNS Drug Discov. 2013 Dec;8(3):235-42. doi: 10.2174/1574889808666131128105630. Recent Pat CNS Drug Discov. 2013. PMID: 24286449 Review.
Transglutaminase activity has been suggested to be involved in molecular mechanisms responsible for both physiological or pathological processes. For example, neurodegenerative diseases, such as Alzheimer's Disease, Parkinson's Disease, supranuclear palsy, Huntin
Transglutaminase activity has been suggested to be involved in molecular mechanisms responsible for both physiological or pathological proce …
78 results